Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A pharmacogenetic study of escitalopram in autism spectrum disorders.

Autism research : official journal of the International Society for Autism Research - 1 Feb 2010

Owley Thomas, Brune Camille W, Salt Jeff, Walton Laura, Guter Steve, Ayuyao Nelson, Gibbons Robert D, Leventhal Bennett L, Cook Edwin H

Abstract excerpt

OBJECTIVE: To determine the effect of serotonin transporter polymorphism promoter region (5-HTTPLR) genotypic variation (low, intermediate, and high expression groups) on response to escitalopram treatment of children and adolescents with autism spectrum disorders (ASDs). METHOD: The study used a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents, Second-Generation
Share to Blood Platelets

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child Development Disorders, Pervasive

Share to Citalopram

Share to Personality Assessment

Share to Selective Serotonin Reuptake Inhibitors

Share to Serotonin

Share to Serotonin Plasma Membrane Transport Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 20020537
DOI: 10.1002/aur.109
PMCID: PMC2937270

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20020537-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A pharmacogenetic study of escitalopram in autism spectrum disorders.PMID 20020537Read ↗

Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in Autism.Semantic proximity Read ↗

Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia.Semantic proximity Read ↗

The polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among Saudi children with autism.Semantic proximity Read ↗

Serotonin transporter promoter variants: Analysis in Indian autistic and control population.Semantic proximity Read ↗

Evidence for an association with the serotonin transporter promoter region polymorphism and autism.Semantic proximity Read ↗

5-HTTLPR Genotype-Specific Phenotype in Children and Adolescents With Autism.Semantic proximity Read ↗

Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults.Semantic proximity Read ↗

The involvement of serotonin polymorphisms in autistic spectrum symptomatology.Semantic proximity Read ↗

Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism.Semantic proximity Read ↗

Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population.Semantic proximity Read ↗

The role of 5-HTTLPR in autism spectrum disorder: New evidence and a meta-analysis of this polymorphism in Latin American population with psychiatric disorders.Semantic proximity Read ↗

Allele-specific associations of 5-HTTLPR/rs25531 with ADHD and autism spectrum disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.